Diagnostics News and Research

RSS

New, cross-sector collaboration aims to discover clinical biomarker for pancreatic cancer

The search to discover and validate the first-ever clinical biomarker to diagnose and treat pancreatic cancer is at the foundation of a new, cross-sector collaboration. Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach; the Cancer Center at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, and the Pancreatic Cancer Research Team managed by Cancer Research And Biostatistics announced today they will work together to eradicate the disease.

9 Apr 2015

MammaPrint 70-gene breast cancer recurrence assay recommended in Germany’s AGO Guidelines

Agendia, a leading molecular diagnostics company that develops and markets genomic diagnostic products, announced at the St. Gallen International Breast Cancer Conference that new guidelines of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) recommend the MammaPrint® 70-gene breast cancer recurrence assay in Germany’s 2015 guidelines for early-stage invasive breast cancer.

9 Apr 2015

Study suggests that pancreatic cancers harbor genetic alterations

A genetic analysis led by UT Southwestern Medical Center researchers suggests that most pancreatic cancers harbor genetic alterations that could be targeted by existing drugs, using their genetic features as a roadmap for treatment. The findings support a precision approach to treating pancreatic cancer, the fourth most deadly cancer for both men and women.

9 Apr 2015

Plymouth researchers receive grant to develop effective therapy for Huntington's disease

Huntington's disease is an hereditary disorder of the nervous system caused by a faulty gene on chromosome four. The faulty gene leads to nerve damage in the area of the brain resulting in gradual physical, mental and emotional changes. Those born to a parent with Huntington's disease have a 50:50 chance of developing it, and there is currently no cure.

9 Apr 2015

Mobidiag announces CE-IVD marking and launching of Amplidiag C. difficile+027 test

Mobidiag Ltd, a Finnish molecular diagnostics company specialized in the development of innovative diagnostics solutions for infectious diseases, today announced the launch of Amplidiag C. difficile+027, a qualitative qPCR-based test performed from DNA extracted from stool in suspected cases of C. difficile infection (CDI).

9 Apr 2015

Frost & Sullivan forecasts growth of global healthcare market

The healthcare industry is entangled in a transitory phase in which therapeutics, devices, products and services are sold into traditional care settings that are unable to keep up with the requirements placed upon it by changing demographics and consumer needs. At the same time, opportunities for new services and care, such as ambulatory, mobile, and home care, lack the appropriate level of maturity to provide robust revenue streams despite having the promise to increase healthcare delivery efficiency and reduce long term costs.

8 Apr 2015

Qualcomm Life launches HealthyCircles Mobile app

Qualcomm Incorporated today announced that its subsidiary, Qualcomm Life, Inc., launched the HealthyCircles Mobile application, a secure, medical-grade mobile care solution that provides a frictionless on-the-go care experience for consumers via their mobile device.

8 Apr 2015

UT researchers receive 2.5 million euros from European Commission for TransGeno project

The European Commission supports the TransGeno project of UT researchers with 2.5 million euros. This support helps to recruit top researchers to work at the ERA Chair of Translational Genomics of the University of Tartu soon to be created. The research work done at the new chair will advance research in translational genomics, so that in the future, doctors would be able to diagnose diseases as early as possible, thus improving opportunities for treatment.

8 Apr 2015

Diagnostics Direct introduces CLIA approved diagnostic test, Syphilis Health Check

Diagnostics Direct, LLC., a leading provider of in-office diagnostic tests, is pleased to announce the launch of the first CLIA-Waived rapid treponemal syphilis test: Syphilis Health Check™.

7 Apr 2015

New study sheds light on linguistic characteristic of autistic children

A new study by a linguistics professor and an alumnus from The University of Texas at Austin sheds light on a well-known linguistic characteristic of autistic children — their reluctance to use pronouns — paving the way for more accurate diagnostics.

6 Apr 2015

Findings of Ariosa's non-invasive prenatal testing study published online in NEJM

Results from the largest clinical trial to date, comparing non-invasive prenatal testing (NIPT) using the Harmony Prenatal Test with conventional first trimester combined screening (FTS) in a general pregnancy population have been published online in The New England Journal of Medicine.

6 Apr 2015

Symposium to highlight latest thinking related to obesity

The 15th Plymouth Obesity, Diabetes and Metabolic Syndrome Symposium will take place at Plymouth Postgraduate Medical Centre on 21st May.

6 Apr 2015

CentoMD: World's largest genetic mutation database for rare diseases

CENTOGENE AG announces the launch of the world's largest genetic mutation database for rare diseases, CentoMD. CentoMD is a comprehensive and unique repository of genetic variants, including a huge number of unpublished pathogenic variants gathered from patients worldwide.

3 Apr 2015

Orofacial pain specialists at Case Western Reserve University treat complex health issues

Andres Pinto, an orofacial pain and oral medicine specialist at Case Western Reserve University School of Dental Medicine, often feels like the doctor in the television series House, who solves medical mysteries each week.

3 Apr 2015

Novel biosensing platform could remotely determine treatment options for HIV, E-coli

In much the same way that glucometers and pregnancy tests have revolutionized in-home diagnostic testing, researchers from Florida Atlantic University and collaborators have identified a new biosensing platform that could be used to remotely detect and determine treatment options for HIV, E-coli, Staphylococcus aureas and other bacteria.

3 Apr 2015

Quest Diagnostics grants Supplier Excellence Awards to five companies

Quest Diagnostics, the world's leading provider of diagnostic information services, today awarded Supplier Excellence Awards to five companies at its 2015 Supplier Forum.

From Quest Diagnostics 2 Apr 2015

New prenatal test introduced for detecting Down’s Syndrome

A new prenatal test for Down’s Syndrome may be more effective at diagnosing the condition than the standard screening that is currently used, suggests a study published in the New England Journal of Medicine.

2 Apr 2015

BioLight forms strategic partnership with Rock-One to expand its presence within China

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced today an agreement to enter into a strategic partnership with Rock-One International Holdings Ltd., a holding company specializing in investment activities, including in the high tech and biomedical industries.

2 Apr 2015

Study: APOSEC protein concentrate reduces severity of damage after spinal cord injuries

In tests conducted on animals, the APOSEC protein concentrate extracted from white blood cells has reduced the severity of damage after an accident involving spinal cord injuries when the agent was injected in the abdominal cavity 40 minutes after the acute lesion. As a result, severe consequential paralyses can be prevented.

2 Apr 2015

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

31 Mar 2015

Diagnostics News and Research

New, cross-sector collaboration aims to discover clinical biomarker for pancreatic cancer

MammaPrint 70-gene breast cancer recurrence assay recommended in Germany’s AGO Guidelines

Study suggests that pancreatic cancers harbor genetic alterations

Plymouth researchers receive grant to develop effective therapy for Huntington's disease

Mobidiag announces CE-IVD marking and launching of Amplidiag C. difficile+027 test

Frost & Sullivan forecasts growth of global healthcare market

Qualcomm Life launches HealthyCircles Mobile app

UT researchers receive 2.5 million euros from European Commission for TransGeno project

Diagnostics Direct introduces CLIA approved diagnostic test, Syphilis Health Check

New study sheds light on linguistic characteristic of autistic children

Findings of Ariosa's non-invasive prenatal testing study published online in NEJM

Symposium to highlight latest thinking related to obesity

CentoMD: World's largest genetic mutation database for rare diseases

Orofacial pain specialists at Case Western Reserve University treat complex health issues

Novel biosensing platform could remotely determine treatment options for HIV, E-coli

Quest Diagnostics grants Supplier Excellence Awards to five companies

New prenatal test introduced for detecting Down’s Syndrome

BioLight forms strategic partnership with Rock-One to expand its presence within China

Study: APOSEC protein concentrate reduces severity of damage after spinal cord injuries

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News